In announcing the move, health agency officials stated that the rule would have imposed too high a burden on nursing homes, particularly in rural areas, where they noted that nursing staff are in ...

As part of its ongoing Chapter 11 bankruptcy proceedings, 23andMe Holding Co. - now named Chrome Holding - has reached a ...

If your estate plan was created before the DNA testing era—or hasn't been updated to account for these new realities—now is ...

A lawyer representing the Brown sisters and their mother said their grief was “compounded by this putative heir all of a sudden showing up and demanding money” ...

Canadians affected by a 23andMe data security breach two years ago have reached a proposed class-action settlement with the ...

Surprise heirs are showing up because of DNA test kits and sowing disorder for people handling their loved ones’ estates.

The sale of 23andMe was finalized this week, following the company filing for bankruptcy in March. The sale was previously approved by a judge. The company was purchased by the nonprofit TTAM Research ...

A bankruptcy judge approved the sale of genetics company 23andMe to a non-profit led by co-founder and former CEO Anne Wojcicki, according to a June 27 filing in the bankruptcy docket. TTAM Research ...

The UK Information Commissioner's Office (ICO) has fined genetic testing provider 23andMe £2.31 million ($3.12 million) over 'serious security failings' that led to a 'profoundly damaging' data breach ...

Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” according to a spokesperson for the pharma. Just weeks after it pledged $256 ...

Dozens of states have filed a joint lawsuit against the bankrupt DNA-testing company 23andMe to block the company’s sale of its customers’ genetic data without explicit consent. The suit, filed this ...

Bankrupt 23andMe is facing a lawsuit over its plans to sell customer genetic information. Twenty-seven states and the District of Columbia took legal action this week against 23andMe in the U.S.